Advertisement
Screener

EVOFEM BIOSCIENCES, INC. (EVFM) Revenues

2.8 / 5 stars · 68/120 Roast Me

EVOFEM BIOSCIENCES, INC. Revenues

EVOFEM BIOSCIENCES, INC. (EVFM) reported Revenues of $100.00 million for the 1-month period ending 2023-10-31, per its 10-Q filed 2023-11-14.

Discontinued › Income Statement

us-gaap:Revenues · last filed 2023-11-14

  • EVOFEM BIOSCIENCES, INC. revenues for the quarter ending 2022-12-31 was $181.00K, a 94.93% decline year-over-year.
  • EVOFEM BIOSCIENCES, INC. revenues for the quarter ending 2022-09-30 was $6.37M, a 272.14% increase year-over-year.
  • EVOFEM BIOSCIENCES, INC. revenues for the quarter ending 2022-06-30 was $6.03M, a 224.93% increase year-over-year.
  • EVOFEM BIOSCIENCES, INC. revenues for the quarter ending 2022-03-31 was $4.25M, a 284.71% increase year-over-year.
  • EVOFEM BIOSCIENCES, INC. revenues for fiscal 2022 was $16.84M, a 104.23% increase from fiscal 2021.
  • EVOFEM BIOSCIENCES, INC. revenues for fiscal 2021 was $8.24M, a 1748.43% increase from fiscal 2020.
  • EVOFEM BIOSCIENCES, INC. revenues for fiscal 2020 was $446.00K.
  • EVOFEM BIOSCIENCES, INC. revenues for fiscal 2019 was $0.00.
Period endRevenues 1 monthRevenues 3 monthRevenues 6 monthRevenues 9 monthRevenues 12 month
2023-10-31$100.00M
10-Q · filed 2023-11-14
2022-12-31$181.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-27
$6.55M
derived: sum of 2 quarters · filed 2023-04-27
$12.59M
derived: sum of 3 quarters · filed 2023-04-27
$16.84M
10-K · filed 2023-04-27
2022-09-30$6.37M
10-Q · filed 2023-01-06
$12.40M
derived: sum of 2 quarters · filed 2023-01-06
$16.66M
10-Q · filed 2023-01-06
$20.23M
derived: sum of 4 quarters · filed 2023-04-27
2022-06-30$6.03M
10-Q · filed 2022-08-12
$10.29M
10-Q · filed 2022-08-12
$13.86M
derived: sum of 3 quarters · filed 2023-04-27
$15.57M
derived: sum of 4 quarters · filed 2023-04-27
2022-03-31$4.25M
10-Q · filed 2022-05-10
$7.82M
derived: sum of 2 quarters · filed 2023-04-27
$9.53M
derived: sum of 3 quarters · filed 2023-04-27
$11.39M
derived: sum of 4 quarters · filed 2023-04-27
2021-12-31$3.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-27
$5.28M
derived: sum of 2 quarters · filed 2023-04-27
$7.14M
derived: sum of 3 quarters · filed 2023-04-27
$8.24M
10-K · filed 2023-04-27
2021-09-30$1.71M
10-Q · filed 2023-01-06
$3.57M
derived: sum of 2 quarters · filed 2023-01-06
$4.67M
10-Q · filed 2023-01-06
$4.84M
derived: sum of 4 quarters · filed 2023-01-06
2021-06-30$1.86M
10-Q · filed 2022-08-12
$2.96M
10-Q · filed 2022-08-12
$3.13M
derived: sum of 3 quarters · filed 2022-08-12
$3.41M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$1.10M
10-Q · filed 2022-05-10
$1.27M
derived: sum of 2 quarters · filed 2022-05-10
$1.55M
derived: sum of 3 quarters · filed 2022-05-10
$1.55M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$168.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$446.00K
derived: sum of 2 quarters · filed 2022-03-10
$446.00K
derived: sum of 3 quarters · filed 2022-03-10
$446.00K
10-K · filed 2022-03-10
2020-09-30$278.00K
10-Q · filed 2021-11-15
$278.00K
derived: sum of 2 quarters · filed 2021-11-15
$278.00K
10-Q · filed 2021-11-15
$278.00K
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$0.00
10-Q · filed 2021-08-11
$0.00
10-Q · filed 2021-08-11
$0.00
derived: sum of 3 quarters · filed 2021-08-11
$0.00
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$0.00
10-Q · filed 2021-05-06
$0.00
derived: sum of 2 quarters · filed 2021-05-06
$0.00
derived: sum of 3 quarters · filed 2021-05-06
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04
$0.00
derived: sum of 2 quarters · filed 2021-03-04
$0.00
10-K · filed 2021-03-04
2019-09-30$0.00
10-Q · filed 2020-11-09
$0.00
10-Q · filed 2020-11-09